Management of Renal Disease

  • Author: Mohamed G. Atta, MD, MPH (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 3/14/17 (What's New)

Summary

  • Deterioration of renal function due to HIVAN among patients not receiving ART is rapid (generally within months)[Ifudu 1995; Rao 1984; Alpers 1988; Langs 1990; Valeri 1991]
  • In general, studies of antiretroviral treatments consistently support strong benefit for HIVAN and its progression
  • HIVAN treatment includes ART, ACE inhibitors/angiotensin receptor blockers, and glucocorticoids[Atta 2010]

Action required

Keywords: Renal Complications, Treatment Complications

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.